Achieving a Complete Molecular Remission Under Imatinib Therapy Is Associated with a Better Outcome in Chronic Phase Chronic Myeloid Leukaemia Patients On Imatinib Frontline Therapy

被引：0
|
作者：
Etienne, Gabriel [8 ]
Nicolini, Nicolini E. [1 ]
Dulucq, Stephanie
Schmitt, Anna [8 ]
Hayette, Sandrine
Lippert, Eric [2 ]
Tigaud, Isabelle [3 ]
Morisset, Stephane [4 ]
Bureau, Caroline [5 ]
Adiko, Didier [6 ]
Marit, Gerald [7 ]
Reiffers, Josy [8 ]
Mahon, Francois-Xavier [9 ]
机构：
[1] Univ Lyon 1, Hop Edouard Herriot, HCL, F-69365 Lyon, France
[2] Ctr Hosp Univ, Lab Hematol, Bordeaux, France
[3] Ctr Hosp Lyon Sud, Lab Mol Biol & Cytogenet, F-69310 Pierre Benite, France
[4] Ctr Hosp Lyon Sud, Dept Hematol, F-69310 Pierre Benite, France
[5] Polyclin Bordeaux Nord Aquitaine, Bordeaux, France
[6] Hop Robert Boulin, Libourne, France
[7] CHU, Serv Hematol Clin & Therapie Cellulaire, Pessac, France
[8] Univ Victor Segalen Bordeaux, Inst Bergonie, Bordeaux, France
[9] CHU Bordeaux, Dept Hematol, Hop Pellegrin, INSERM 1035, Bordeaux, France
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.3754.3754
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3754
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Imatinib discontinuation: realistic for patients with chronic myeloid leukaemia achieving complete molecular remission?
    Stagno, Fabio
    Vigneri, Paolo
    Di Raimondo, Francesco
    LANCET ONCOLOGY, 2011, 12 (02): : 118 - 118
  • [2] Adherence to imatinib therapy is the critical factor for achieving molecular responses in patients with chronic myeloid leukaemia
    Marin, D.
    Milojkovic, D.
    Bua, M.
    Apperley, J.
    Reid, A.
    Rezvani, K.
    Foroni, L.
    Goldman, J.
    Marin, D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 81 - 81
  • [3] Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline
    Monica Crugnola
    Fausto Castagnetti
    Massimo Breccia
    Dario Ferrero
    Malgorzata Monika Trawinska
    Elisabetta Abruzzese
    Mario Annunziata
    Fabio Stagno
    Mario Tiribelli
    Gianni Binotto
    Massimiliano Bonifacio
    Carmen Fava
    Alessandra Iurlo
    Cristina Bucelli
    Giovanna Mansueto
    Antonella Gozzini
    Franca Falzetti
    Enrico Montefusco
    Elena Crisà
    Gabriele Gugliotta
    Sabina Russo
    Michele Cedrone
    Antonella RussoRossi
    Patrizia Pregno
    Alessandro Isidori
    Endri Mauro
    Romano Atelda
    Gianfranco Giglio
    Francesca Celesti
    Federica Sorà
    Sergio Storti
    Adam D’Addosio
    Sara Galimberti
    Ester Orlandi
    Elisabetta Calistri
    Monica Bocchia
    Francesco Cavazzini
    Giovanna Rege Cambrin
    Nicola Orofino
    Luigiana Luciano
    Nicola Sgherza
    Gianantonio Rosti
    Roberto Latagliata
    Isabella Capodanno
    Annals of Hematology, 2019, 98 : 2329 - 2338
  • [4] Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline
    Crugnola, Monica
    Castagnetti, Fausto
    Breccia, Massimo
    Ferrero, Dario
    Trawinska, Malgorzata Monika
    Abruzzese, Elisabetta
    Annunziata, Mario
    Stagno, Fabio
    Tiribelli, Mario
    Binotto, Gianni
    Bonifacio, Massimiliano
    Fava, Carmen
    Iurlo, Alessandra
    Bucelli, Cristina
    Mansueto, Giovanna
    Gozzini, Antonella
    Falzetti, Franca
    Montefusco, Enrico
    Crisa, Elena
    Gugliotta, Gabriele
    Russo, Sabina
    Cedrone, Michele
    RussoRossi, Antonella
    Pregno, Patrizia
    Isidori, Alessandro
    Mauro, Endri
    Atelda, Romano
    Giglio, Gianfranco
    Celesti, Francesca
    Sora, Federica
    Storti, Sergio
    D'Addosio, Adam
    Galimberti, Sara
    Orlandi, Ester
    Calistri, Elisabetta
    Bocchia, Monica
    Cavazzini, Francesco
    Cambrin, Giovanna Rege
    Orofino, Nicola
    Luciano, Luigiana
    Sgherza, Nicola
    Rosti, Gianantonio
    Latagliata, Roberto
    Capodanno, Isabella
    ANNALS OF HEMATOLOGY, 2019, 98 (10) : 2329 - 2338
  • [5] COMPLETE MOLECULAR RESPONSE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON IMATINIB THERAPY
    Aksenova, E.
    Chelysheva, E.
    Krutov, A.
    Soldatova, I.
    Misiurin, A.
    Vinogradova, O.
    Gusarova, G.
    Zakharova, E.
    Sokolova, M.
    Nemchenko, I.
    Kuznetsov, S.
    Lazareva, O.
    Vorontsova, A.
    Kolosheinova, T.
    Kolosova, L.
    Goryacheva, S.
    Ivanova, T.
    Turkina, A.
    Khoroshko, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 346 - 346
  • [6] Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy
    Etienne, Gabriel
    Dulucq, Stephanie
    Nicolini, Franck-Emmanuel
    Morisset, Stephane
    Fort, Marie-Pierre
    Schmitt, Anna
    Etienne, Madeleine
    Hayette, Sandrine
    Lippert, Eric
    Bureau, Caroline
    Tigaud, Isabelle
    Adiko, Didier
    Marit, Gerald
    Reiffers, Josy
    Mahon, Francois-Xavier
    HAEMATOLOGICA, 2014, 99 (03) : 458 - 464
  • [7] Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia
    Banjar, Haneen
    Ranasinghe, Damith
    Brown, Fred
    Adelson, David
    Kroger, Trent
    Leclercq, Tamara
    White, Deborah
    Hughes, Timothy
    Chaudhri, Naeem
    PLOS ONE, 2017, 12 (01):
  • [8] IMATINIB AND ITS CLINICAL ASSOCIATED OUTCOME IN CHRONIC MYELOID LEUKAEMIA PATIENTS
    Singh, A. K.
    Vidyadhari, A.
    VALUE IN HEALTH, 2020, 23 : S29 - S29
  • [9] Complete molecular remission in chronic myelogenous leukemia after imatinib therapy
    Barbany, G
    Höglund, M
    Simonsson, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07): : 539 - 540
  • [10] SUCCESSFUL PREGNANCIES IN CHRONIC MYELOID LEUKAEMIA MALE PATIENTS ON IMATINIB THERAPY
    Luciano, L.
    Cerchione, C.
    Ciancia, R.
    Pane, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 541 - 541
12345